Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a new revision has been applied.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe site displays an updated revision tag (v3.6.3) replacing the previous version (v3.6.2), indicating a minor update to the page’s implementation.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's revision history now shows the latest revision as v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check52 days agoChange DetectedNew help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a Revision: v3.6.0 banner were added, while older labels such as Verified, Last known status was:, and the Intervention / Treatment heading were removed, reflecting a UI/content refresh rather than changes to the study data.SummaryDifference1%

- Check59 days agoChange DetectedThe page's revision metadata was updated to v3.5.5, adding last known status, organization (University College, London), date (2024-05), and verification status, while the previous revision indicator v3.5.4 was removed.SummaryDifference0.4%

- Check81 days agoChange DetectedA new revision entry (v3.5.4) was added and the previous revision entry (v3.5.3) was removed in the page's revision history, indicating a standard version update to the page.SummaryDifference0.1%

Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.